These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1819700)

  • 1. A specific, sensitive and high-capacity immunoassay for PAF.
    Baldo BA; Smal MA; McCaskill AC
    Lipids; 1991 Dec; 26(12):1136-9. PubMed ID: 1819700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunoassay for platelet-activating factor.
    Karasawa K; Satoh N; Hongo T; Nakagawa Y; Setaka M; Nojima S
    Lipids; 1991 Dec; 26(12):1126-9. PubMed ID: 1819698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific binding of antibodies to platelet-activating factor (PAF) as demonstrated by thin-layer chromatography/immunostaining.
    Karasawa K; Satoh N; Hongo T; Nakagawa Y; Setaka M; Nojima S
    Lipids; 1991 Dec; 26(12):1122-5. PubMed ID: 1819697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sensitive and specific radioimmunoassay for platelet-activating factor.
    Wang C; Tai HH
    Lipids; 1992 Mar; 27(3):206-8. PubMed ID: 1522765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sheep platelets as a model for human platelets: evidence for specific PAF (platelet activating factor) receptors.
    Slattery CW; Beaumont DO
    Thromb Res; 1989 Sep; 55(5):569-76. PubMed ID: 2554526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human platelet as a reproducible and sensitive cell for the detection and assay of platelet-activating factor.
    Ekholm J; Tatsumi Y; Nouchi T; Hanahan DJ
    Anal Biochem; 1992 Jul; 204(1):79-84. PubMed ID: 1514698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a sensitive and specific 14C-serotonin release assay for platelet-activating factor (PAF) in human neutrophils.
    Müller S; Nigam S
    J Lipid Mediat; 1990; 2(6):329-41. PubMed ID: 2133275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation by radioimmunoassay of PAF in human saliva.
    Cooney SJ; Smal MA; Baldo BA
    Lipids; 1991 Dec; 26(12):1140-3. PubMed ID: 1819701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet activating factor and sheep platelets: a sensitive new bioassay.
    Moon DG; van der Zee H; Morton KD; Krasodomski JA; Kaplan JE; Fenton JW
    Thromb Res; 1990 Feb; 57(4):551-64. PubMed ID: 2326773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new method of purification and sensitive bioassay of platelet-activating factor (PAF) in human whole blood.
    Shinozaki K; Kawasaki T; Kambayashi J; Sakon M; Shiba E; Uemura Y; Ou M; Iwamoto N; Mori T
    Life Sci; 1994; 54(6):429-37. PubMed ID: 8295490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A specific, sensitive radioimmunoassay for platelet-activating factor (PAF).
    Smal MA; Baldo BA; McCaskill A
    J Immunol Methods; 1990 Apr; 128(2):183-8. PubMed ID: 2324511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining site specificities of rabbit antibodies to platelet-activating factor (PAF).
    Cooney SJ; Smal MA; Harle DG; Baldo BA
    Mol Immunol; 1990 May; 27(5):405-12. PubMed ID: 2366757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and characterization of antibodies to platelet-activating factor.
    Macpherson JL; Spur B; Pyne SG; Heymans F; Cox MF; Godfroid JJ; Krilis SA
    J Lipid Mediat; 1992 Feb; 5(1):49-59. PubMed ID: 1391739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to synthetic platelet-activating factor (1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine) analogues with substituents at the sn-2 position.
    Karasawa K; Satoh N; Masuda M; Setaka M; Hashimoto K; Ishibashi K; Nojima S
    J Biochem; 1991 Nov; 110(5):683-7. PubMed ID: 1723729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitor(s) of platelet-activating factor (PAF) in human saliva.
    Smal MA; Baldo BA
    Lipids; 1991 Dec; 26(12):1144-7. PubMed ID: 1819702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure to detect platelet-activating factor using the splenectomized mouse bioassay.
    Scodras JM; Betteridge KJ; Croy BA; Johnstone IB; Rieger D
    J Reprod Fertil; 1991 Jul; 92(2):483-94. PubMed ID: 1886104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and characterization of specific antibodies against 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a potent hypotensive and platelet-activating ether-linked phospholipid).
    Nishihira J; Ishibashi T; Imai Y
    J Biochem; 1984 May; 95(5):1247-51. PubMed ID: 6430883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of phospholipid platelet-activating factor (1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in human amniotic fluid and urine.
    Billah MM; Johnston JM
    Biochem Biophys Res Commun; 1983 May; 113(1):51-8. PubMed ID: 6407483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin induces non-enzymatic formation of platelet-activating factor from lyso platelet-activating factor.
    Mabuchi-Itoh K; Sugiura T; Cheng NN; Waku K
    FEBS Lett; 1993 Oct; 332(3):233-6. PubMed ID: 8405463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. II. Relationships between chemical structure and inhibition of PAF-induced human platelet activation.
    Ostermann G; Hofmann B; Kertscher HP; Till U
    J Lipid Mediat; 1991; 3(2):225-37. PubMed ID: 1797154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.